Cwm, LLC Alkermes Plc. Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Cwm, LLC holds 20,450 shares of ALKS stock, worth $633,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,450

Previous 20,364 0.42%

Holding current value

$633,950

Previous $586,000 15.19%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$28.08 - $36.0 $2,414 - $3,096	86 Added 0.42%	20,450 $675,000
Q4 2024 Feb 04, 2025	BUY	$25.7 - $31.46 $149,496 - $183,002	5,817 Added 39.99%	20,364 $586,000
Q3 2024 Oct 08, 2024	BUY	$23.01 - $28.55 $152,211 - $188,858	6,615 Added 83.4%	14,547 $407,000
Q2 2024 Jul 09, 2024	BUY	$23.21 - $27.24 $120,692 - $141,648	5,200 Added 190.34%	7,932 $191,000
Q1 2024 Apr 05, 2024	BUY	$26.4 - $32.56 $19,351 - $23,866	733 Added 36.67%	2,732 $74,000
Q4 2023 Feb 01, 2024	BUY	$23.37 - $28.68 $22,481 - $27,590	962 Added 92.77%	1,999 $55,000
Q3 2023 Oct 11, 2023	BUY	$27.17 - $31.97 $16,791 - $19,757	618 Added 147.49%	1,037 $29,000
Q2 2023 Aug 03, 2023	BUY	$28.34 - $33.63 $5,242 - $6,221	185 Added 79.06%	419 $13,000
Q1 2023 Apr 28, 2023	BUY	$25.31 - $29.02 $1,746 - $2,002	69 Added 41.82%	234 $7,000
Q4 2022 Feb 01, 2023	BUY	$21.94 - $26.24 $1,623 - $1,941	74 Added 81.32%	165 $4,000
Q3 2022 Oct 27, 2022	SELL	$22.0 - $31.87 $1,760 - $2,549	-80 Reduced 46.78%	91 $2,000
Q2 2022 Jul 28, 2022	BUY	$26.4 - $30.54 $1,399 - $1,618	53 Added 44.92%	171 $5,000
Q1 2022 Apr 21, 2022	BUY	$23.07 - $27.99 $738 - $895	32 Added 37.21%	118 $3,000
Q4 2021 Jan 31, 2022	BUY	$21.47 - $32.08 $1,610 - $2,406	75 Added 681.82%	86 $2,000
Q1 2021 Sep 15, 2021	BUY	$18.21 - $23.2 $200 - $255	11 New	11 $0
Q1 2021 Apr 27, 2021	SELL	$18.21 - $23.2 $200 - $255	-11 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$15.39 - $22.1 $169 - $243	11 New	11 $0
Q4 2020 Jan 27, 2021	SELL	$15.39 - $22.1 $169 - $243	-11 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$16.16 - $20.66 $177 - $227	11 New	11 $0
Q3 2020 Oct 19, 2020	SELL	$16.16 - $20.66 $177 - $227	-11 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$13.31 - $19.41 $146 - $213	11 New	11 $0
Q2 2020 Jul 22, 2020	SELL	$13.31 - $19.41 $146 - $213	-11 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$13.06 - $21.24 $143 - $233	11 New	11 $0
Q1 2020 Apr 28, 2020	SELL	$13.06 - $21.24 $143 - $233	-11 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$17.29 - $21.74 $190 - $239	11 New	11 $0
Q4 2019 Jan 27, 2020	SELL	$17.29 - $21.74 $190 - $239	-11 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$19.51 - $24.28 $214 - $267	11 New	11 $0
Q3 2019 Oct 22, 2019	SELL	$19.51 - $24.28 $214 - $267	-11 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$21.47 - $37.33 $236 - $410	11 New	11 $0
Q2 2019 Jul 31, 2019	SELL	$21.47 - $37.33 $236 - $410	-11 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$28.4 - $36.49 $312 - $401	11 New	11 $0
Q1 2019 Apr 22, 2019	SELL	$28.4 - $36.49 $340 - $437	-12 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$27.94 - $44.61 $5,671 - $9,055	-203 Reduced 94.42%	12 $0
Q3 2018 Oct 29, 2018	BUY	$38.6 - $46.12 $8,299 - $9,915	215 New	215 $9,000

Others Institutions Holding ALKS

# of Institutions

410

Shares Held

177M

Call Options Held

229K

Put Options Held

436K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.09B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account